Official Synedica Europe | European Shipping | Secure Checkout

Peptide Profiles

NAD+ in Research: Why a Coenzyme Sits Next to the Peptides

NAD+ is the odd one out in this series: it is not a peptide at all. It earns its place because almost every metabolic research programme runs into it eventually.

Synedica Research DeskPublished 5 Sept 2026Reviewed 11 Sept 20267 min read
Amber and clear laboratory vials with a notebook on a light wooden surface

It is worth saying up front: nicotinamide adenine dinucleotide is a coenzyme, not a peptide. No amino acids, no peptide bonds. It is here because if you spend any time in metabolic or ageing research, NAD+ turns up in the discussion section of nearly every paper you read.

What the molecule does

NAD+ is an electron carrier. It shuttles between its oxidised form, NAD+, and its reduced form, NADH, moving electrons through glycolysis, the citric acid cycle and oxidative phosphorylation. Without it, cellular energy production stops — this is genuinely foundational biochemistry rather than a fashionable claim.

Its second job is what made it interesting to ageing researchers. NAD+ is consumed as a substrate — not merely recycled — by three enzyme families: the sirtuins, the PARPs involved in DNA repair, and CD38. Every time one of those enzymes works, a molecule of NAD+ is spent.

The decline hypothesis

Multiple groups have measured lower tissue NAD+ concentrations in older animals and in some human tissue samples. That observation, combined with the sirtuin literature, produced the hypothesis that supporting NAD+ availability might influence age-related cellular decline. It is a serious research question with real experimental support in model organisms — and it is still a hypothesis in humans.

  • Sirtuin-dependent deacetylation studies in cell culture.
  • PARP activity and DNA-damage-response work.
  • Rodent studies using NAD+ precursors such as NMN and NR.
  • Human observational measurement of tissue and blood NAD+ levels.

NAD+ material supplied for research is not a medicine or a supplement, and no health claim is made for it here. Human evidence for precursor supplementation remains mixed and early.

Handling: light and moisture are the enemies

NAD+ is noticeably less forgiving than a lyophilised peptide. It is hygroscopic, so an open vial pulls water out of the air, and it degrades under light and at alkaline pH. In solution it is not a material you leave sitting on a bench between steps.

  1. 1Store the sealed vial cold, dry and in the dark — amber glass or a light-proof box.
  2. 2Equilibrate before opening so condensation does not settle on the powder.
  3. 3Prepare solutions immediately before use where the protocol allows it.
  4. 4Keep prepared solutions cold, shielded from light and clearly dated.

Why it appears in kit form

Because it is handled alongside peptide work in practice, NAD+ is often supplied in the same kit format — vial, diluent, consumables — so that the whole workflow stays inside one sterile, documented process. The material differs; the discipline around it does not.

Related products

See all

Frequently asked questions

Is NAD+ a peptide?

No. It is a dinucleotide coenzyme. It appears alongside peptides because it features in the same metabolic and ageing research programmes.

Why is it so light-sensitive?

The nicotinamide and adenine ring systems degrade under light and alkaline conditions, so amber or light-proof storage is standard.

What about NMN and NR?

They are precursors studied as routes to raising NAD+ availability. They are distinct molecules with their own literature.

Sources and further reading

About the author

Synedica Research Desk

Scientific content team

The Synedica Research Desk writes and maintains the technical library behind the Synedica Europe catalogue. The team compiles publicly available literature, supplier documentation and analytical data into plain-language explainers for laboratory and research audiences.

  • Reviews certificates of analysis supplied with every Synedica batch
  • Sources claims from peer-reviewed literature and regulator publications
  • Publishes review dates and correction notes on every article
suporte@synedica.com.py

Continue reading

See all
Back to the Synedica Blog